Read by QxMD icon Read

Journal of Oncology Practice

Manali I Patel, David Moore, Jay Bhattacharya, Arnold Milstein, Tumaini R Coker
INTRODUCTION: Despite advancements in cancer care, persistent gaps remain in the delivery of high-value end-of-life cancer care. The aim of this study was to examine views of health care payer organization stakeholders on approaches to the redesign of end-of-life cancer care delivery strategies to improve care. METHODS: We conducted semistructured interviews with 34 key stakeholders (eg, chief medical officers, medical directors) in 12 health plans and 22 medical group organizations across the United States...
November 16, 2018: Journal of Oncology Practice
Amy L Morris, Mohammed Naeem, Torey Murray, Jeremy Sen, Tanya Thomas, Elizabeth Daniels, Kathlene DeGregory, Jessica Lewis, Michael Keng
PURPOSE: Twenty percent of patients with acute myeloid leukemia (AML) undergoing induction or reinduction chemotherapy at the University of Virginia Health System from May 2011 to August 2014 had a proven or probable invasive fungal infection (IFI). The purpose of our initiative was to reduce the percentage of proven or probable IFIs in patients with AML undergoing induction or reinduction chemotherapy at the University of Virginia Health System to 10% or less by June 2017, in concordance with national averages...
November 15, 2018: Journal of Oncology Practice
Steve Y Lee
No abstract text is available yet for this article.
November 15, 2018: Journal of Oncology Practice
Farah F Quyyumi, Jason D Wright, Melissa K Accordino, Donna Buono, Cynthia W Law, Grace C Hillyer, Alfred I Neugut, Dawn L Hershman
PURPOSE: Follow-up guidelines vary widely among national organizations for patients with early-stage breast cancer treated with curative intent. We sought to evaluate the patterns and predictors of provider follow-up care within the first 5 years after diagnosis. METHODS: Using the SEER-Medicare linked data set, we evaluated patients who were diagnosed with stage I and II breast cancer who underwent breast-conserving surgery from 2002 to 2007 with follow-up until 2012...
November 8, 2018: Journal of Oncology Practice
Justin A Yu, Kristin N Ray, Seo Young Park, Amanda Barry, Cardinale B Smith, Peter G Ellis, Yael Schenker
PURPOSE: The proportion of patients with advanced cancer who receive outpatient specialty palliative care (OSPC) is as low as 2.0%. Improved understanding of the system-level factors influencing use of OSPC could inform adaptations to the delivery of palliative care to maximize access. We examined associations between OSPC use among patients with advanced solid tumors and oncology-OSPC clinic colocation and patient travel time to an OSPC clinic. PATIENTS AND METHODS: We conducted a retrospective cohort study of patients with advanced solid tumors receiving oncologic treatment between January 1 and December 31, 2016, within a comprehensive cancer center network with well-established, oncology-specific OSPC clinics...
November 8, 2018: Journal of Oncology Practice
Danielle Gentile, Merry Jennifer Markham, Tara Eaton
Social media (SM) platforms such as Facebook, Instagram, Twitter, and online cancer support groups are an emerging source of social support. However, oncology care professionals may be unfamiliar with how patients use SM related to their cancer diagnosis. SM can be potentially beneficial by providing an avenue for patient engagement and empowerment, increasing psychosocial and informational support, strengthening patient-physician relationships, and relaying opportunities for clinical and research study participation...
November 1, 2018: Journal of Oncology Practice
Lucio Gordan, Marlo Blazer, Vishal Saundankar, Denise Kazzaz, Susan Weidner, Michael Eaddy
PURPOSE: Access to high-quality cancer care remains a challenge for many patients. One such barrier is the increasing cost of treatment. With recent shifts in cancer care delivery from community-based to hospital-based clinics, we examined whether this shift could result in increased costs for patients with three common tumor types. METHODS: Cost data for 6,675 patients with breast, lung, and colorectal cancer were extracted from the IMS LifeLink database and analyzed as cost per patient per month (PPPM)...
October 31, 2018: Journal of Oncology Practice
Teresa L Deshields, Hillary L Howrey, Jessica R Vanderlan
No abstract text is available yet for this article.
October 24, 2018: Journal of Oncology Practice
Thomas G Knight, Allison M Deal, Stacie B Dusetzina, Hyman B Muss, Seul Ki Choi, Jeannette T Bensen, Grant R Williams
PURPOSE: Because of the escalating cost of cancer care coupled with high insurance deductibles, premiums, and uninsured populations, patients with cancer are affected by treatment-related financial harm, known as financial toxicity. The purpose of this study was to describe individuals reporting financial toxicity and to identify rates of and reasons for affordability-related treatment noncompliance. METHODS: From May 2010 to November 2015, adult patients (age ≥ 18 years) with cancer were identified from a Health Registry/Cancer Survivorship Cohort...
October 24, 2018: Journal of Oncology Practice
Tanya Gupta, Lidia Schapira
Online communities are virtual spaces dedicated to hosting conversations between individuals with a common interest. Information can be shared and obtained incrementally, as users can periodically post both questions and responses to other users' questions. Although online communities have been used frequently by patients for a myriad of health issues, much remains to be learned about these resources. In this commentary, we explore the emerging role of online communities as forums for information exchange and sources of support for patients with cancer and caregivers...
October 18, 2018: Journal of Oncology Practice
Santosh Gautam, Gosia Sylwestrzak, John Barron, Xiaoxue Chen, Michael Eleff, David Debono, Ann Nguyen, Michael Fisch
PURPOSE: Pathway regimens are value-driven, evidence-based therapies that aim at high-quality, affordable cancer care. There are few real-world data to support the value of such regimens, especially for patients with breast cancer. MATERIALS AND METHODS: Using nationally representative claims data from Anthem, together with clinical data from its Cancer Care Quality Program, we identified patients with breast cancer for whom chemotherapy was initiated between January 2015 and October 2016...
October 15, 2018: Journal of Oncology Practice
Catherine Conahan, Samuel Booth, Molly Hartley, Amanda Okpoebo, Justin Sun
No abstract text is available yet for this article.
October 10, 2018: Journal of Oncology Practice
Tina W F Yen, Ann B Nattinger, Emily L McGinley, Nicole Fergestrom, Liliana E Pezzin, Purushottam W Laud
PURPOSE: The effect of advanced practice provider (APP) involvement in oncology care on cancer-specific outcomes is unknown. We examined the association between team-based APP-physician care during chemotherapy and chemotherapy-related adverse events (AEs) among women with breast cancer. METHODS: We performed separate nested case-control analyses in two national cohorts of women who received chemotherapy for incident breast cancer. Cohorts were identified from Medicare (≥ 65 years of age) and MarketScan (18 to 64 years of age) data...
October 10, 2018: Journal of Oncology Practice
Nicole Mittmann, Hasmik Beglaryan, Ning Liu, Soo Jin Seung, Farah Rahman, Julie Gilbert, Stefanie De Rossi, Craig C Earle, Eva Grunfeld, Victoria Zwicker, Dominique LeBlanc, Jonathan Sussman
BACKGROUND: Transitioning low-risk cancer survivors back to their primary care provider (PCP) has been shown to be safe but the effect on health system resources and costs has not been examined. METHODS: A Well Follow-Up Care Initiative (WFCI) was implemented in the publicly funded health system. Low-risk breast cancer (BC) survivors in the WFCI intervention group were transitioned from oncologist-led cancer clinics to PCPs. We compared health system costs ($2,014 in Canadian dollars) and resource utilization in this intervention group with that in propensity-score-matched nontransitioned BC survivors (ie, controls) diagnosed in the same year, with similar disease profile and patient characteristics using publicly funded administrative databases...
October 5, 2018: Journal of Oncology Practice
Katherine V Ferry-Galow, Vivekananda Datta, Hala R Makhlouf, John Wright, Bradford J Wood, Elliot Levy, Etta D Pisano, Alda L Tam, Susanna I Lee, Umar Mahmood, Lawrence V Rubinstein, James H Doroshow, Alice P Chen
PURPOSE: Research biopsy specimens collected in clinical trials often present requirements beyond those of tumor biopsy specimens collected for diagnostic purposes. Research biopsies underpin hypothesis-driven drug development, pharmacodynamic assessment of molecularly targeted anticancer agents, and, increasingly, genomic assessment for precision medicine; insufficient biopsy specimen quality or quantity therefore compromises the scientific value of a study and the resources devoted to it, as well as each patient's contribution to and potential benefit from a clinical trial...
October 4, 2018: Journal of Oncology Practice
Chebli Mrad, Marwan S Abougergi, Bobby Daly
BACKGROUND: Patients with metastatic lung cancer are treated with palliative intent. Aggressive care at the end of life is a marker of poor-quality care. National trends and factors related to aggressive inpatient care at the end of life for these patients have not been evaluated. METHODS: Patients with stage IV lung cancer and a terminal hospitalization were identified in the National Inpatient Sample database between 1998 and 2014. Longitudinal analysis was conducted to determine trends in aggressive inpatient care at the end of life and multivariate logistic regression was performed to determine associations with patient and hospital characteristics...
September 28, 2018: Journal of Oncology Practice
Molly A Mendenhall, Karyn Dyehouse, Jad Hayes, Joanie Manzo, Teresa Meyer-Smith, Andrew Guinigundo, Brian Bourbeau, David Waterhouse
PURPOSE: The purpose of the Oncology Care Model (OCM) is to improve quality and reduce cost through practice transformation. A foundational tenant is to reduce avoidable emergency room (ER) visits and hospitalizations. In anticipation of being an OCM participant, we instituted a multidimensional campaign designed to meet these objectives. METHODS: Prior actions included establishment of phone triage unit, after-hours and weekend calls, and institution of weekend urgent care...
September 28, 2018: Journal of Oncology Practice
Awad A Ahmed, Stella K Yoo, Shahil Mehta, Emma B Holliday, Curtiland Deville, Neha Vapiwala, Lynn D Wilson, Reshma Jagsi, Vinay Prasad, Charles R Thomas
PURPOSE: Conflict of interest (COI) disclosure is essential to research integrity. The average reading comprehension in English is 3.8 words per second (wps). This study examines presenters at the American Society for Radiation Oncology (ASTRO) national meeting over a recent 3-year period to determine whether disclosure is presented accurately and in a manner that allows the audience to comprehend the content. METHODS: We examined videos of presentations as well as slides from 2014 to 2016 from the ASTRO virtual meeting, noting whether a COI slide was presented, the duration the slide was visible, and the number of disclosures...
September 27, 2018: Journal of Oncology Practice
Samuel J Hong, Edward C Li, Linda M Matusiak, Glen T Schumock
PURPOSE: Recent cancer drug approvals are lauded as being more effective with relatively fewer adverse effects, but these treatments come with a great cost to the US health care system. There is little information on recent trends in actual antineoplastic expenditures representative of the whole US health care system or by sector. Therefore, the objective of this study was to describe antineoplastic expenditures in the United States by year and sector. METHODS: This was a retrospective, cross-sectional study of IQVIA (formerly QuintilesIMS) National Sales Perspective data for the period of January 1, 2011, to December 31, 2016...
September 18, 2018: Journal of Oncology Practice
Randy A Taplitz, Erin B Kennedy, Christopher R Flowers
No abstract text is available yet for this article.
September 4, 2018: Journal of Oncology Practice
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"